Compare SRPT & ALKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRPT | ALKT |
|---|---|---|
| Founded | 1980 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 2000 | 2021 |
| Metric | SRPT | ALKT |
|---|---|---|
| Price | $18.68 | $13.76 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 29 | 7 |
| Target Price | $25.85 | ★ $28.57 |
| AVG Volume (30 Days) | ★ 3.0M | 1.6M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.99 | N/A |
| Revenue | ★ $2,198,237,000.00 | $152,159,000.00 |
| Revenue This Year | N/A | $21.85 |
| Revenue Next Year | N/A | $16.90 |
| P/E Ratio | $6.15 | ★ N/A |
| Revenue Growth | 15.58 | ★ 35.68 |
| 52 Week Low | $14.68 | $13.76 |
| 52 Week High | $25.32 | $25.96 |
| Indicator | SRPT | ALKT |
|---|---|---|
| Relative Strength Index (RSI) | 43.84 | 21.95 |
| Support Level | $15.40 | N/A |
| Resistance Level | $23.80 | $17.81 |
| Average True Range (ATR) | 1.30 | 0.99 |
| MACD | -0.41 | -0.68 |
| Stochastic Oscillator | 13.06 | 0.84 |
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
Alkami Technology Inc is a cloud-based digital banking solutions provider. The company offers the Alkami Digital Sales & Service Platform, which includes a digital banking platform, onboarding and account opening solutions, and data and marketing tools. The platform enables financial institutions to onboard and engage users, support revenue growth, and improve operational efficiency through a cloud-based, multi-tenant architecture. The company provides services to clients under software-as-a-service arrangements. It derives substantially all of its revenues from SaaS subscription services charged for the use of digital sales and service solutions.